Posts

Showing posts with the label pulmonary hypertension diagnosis

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Blood test for scleroderma, systemic sclerosis biomarkers launched - Healio

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

10 medical tech innovations to ring in the New Year - MD Linx

10 medical tech innovations to ring in the New Year    MD Linx Ten medical technology innovations and nominees for the 2018 Prix Galien Award.

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel - Odessa American

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel    Odessa American RESEARCH TRIANGLE PARK, N.C. & TORONTO--(BUSINESS WIRE)--Jan 3, 2019--Analytics 4 Life, a digital health company dedicated to improving existing ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - BioSpace

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    BioSpace Published: Jan 09, 2019. LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

8 Trends Affecting Your Work and Health Outcomes in 2019 - Pharmaceutical Executive

8 Trends Affecting Your Work and Health Outcomes in 2019    Pharmaceutical Executive 2018 proved to be a pivotal year, and as we look towards 2019, key foundational policies and recommendations still need to be fleshed out. Here is our look into ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis - PRNewswire

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    PRNewswire LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

The Challenge of Diagnosing Abdominal Pain and Diarrhea - MedPage Today

The Challenge of Diagnosing Abdominal Pain and Diarrhea    MedPage Today Distinguishing between the myriad causes of intestinal symptoms such as abdominal pain, bloating, and persistent diarrhea can be challenging, especially in ...

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel - Odessa American

Analytics 4 Life® Announces Appointment of William Revelos as Vice President and General Counsel    Odessa American RESEARCH TRIANGLE PARK, N.C. & TORONTO--(BUSINESS WIRE)--Jan 3, 2019--Analytics 4 Life, a digital health company dedicated to improving existing ...

Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.